Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

4.38
-0.2000-4.37%
Post-market: 4.410.0300+0.68%17:54 EDT
Volume:1.25M
Turnover:5.50M
Market Cap:608.45M
PE:-1.09
High:4.62
Open:4.58
Low:4.35
Close:4.58
52wk High:14.45
52wk Low:4.16
Shares:138.92M
Float Shares:94.55M
Volume Ratio:1.25
T/O Rate:1.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0061
EPS(LYR):-3.8310
ROE:-46.22%
ROA:-24.73%
PB:0.64
PE(LYR):-1.14

Loading ...

Trump Says Pharma Tariffs Coming Very Soon

Reuters
·
Jun 17

Positive Outlook on Vir Biotechnology’s VIR-5500 Amid Competitive mCRPC Market

TIPRANKS
·
Jun 05

Director Janet Napolitano Reports Disposal of Common Shares in Vir Biotechnology Inc

Reuters
·
Jun 03

Vir Biotechnology Inc. Concluded Annual Stockholders Meeting

Reuters
·
May 30

Vir Biotechnology Price Target Maintained With a $14.00/Share by Needham

Dow Jones
·
May 22

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), Genmab (GMAB) and Vir Biotechnology (VIR)

TIPRANKS
·
May 22

Vir Biotechnology Inc. to Participate in TD Cowen 6th Annual Oncology Innovation Summit

Reuters
·
May 21

Vaccine Stocks Surge with Moderna up 11%

Tiger Newspress
·
May 20

Vir Biotechnology Inc. to Participate in Bank of America Securities 2025 Healthcare Conference

Reuters
·
May 13

Stock Track | Vir Biotechnology Soars 6.10% on Positive Analyst Rating and Trump's Drug Pricing Plan

Stock Track
·
May 12

Vir Biotechnology Is Maintained at Buy by Needham

Dow Jones
·
May 12

Vir Biotechnology (VIR) Receives a Buy from Needham

TIPRANKS
·
May 12

Trump Says He Will Cut Drug Prices by 59%

Reuters
·
May 12

Stock Track | Vir Biotechnology Plummets 5.18% Despite Positive Hepatitis B Treatment Data

Stock Track
·
May 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Vir Biotechnology (VIR) and Liquidia Technologies (LQDA)

TIPRANKS
·
May 09

Stock Track | Vir Biotechnology Plummets 5.43% as Q1 Earnings Miss Estimates, Revenue Drops 94.6%

Stock Track
·
May 08

Stock Track | Vir Biotechnology Surges 6.24% Pre-market Despite Quarterly Loss, Analyst Optimism Prevails

Stock Track
·
May 08

Vir Biotechnology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Vir Biotechnology Q1 EPS $(0.88), Inline, Sales $3.03M Miss $8.59M Estimate

Benzinga
·
May 08

BRIEF-Vir Biotechnology Q1 EPS USD -0.88

Reuters
·
May 08